Masaru Kuranami

1.6k citations

45 papers · 1.3k indexed · h-index 18

Radiology, Nuclear Medicine and Imaging top 2%
Oncology top 10%
- Cancer Treatment and Pharmacology 11
- Cancer survivorship and care 6
- Cancer Diagnosis and Treatment 5
Cancer Research
- Breast Cancer Treatment Studies 8
Pathology and Forensic Medicine top 10%
Dermatology top 10%
- Chemotherapy-related skin toxicity 6
Sociology and Political Science
- Family Support in Illness 6
Pulmonary and Respiratory Medicine
- Gastric Cancer Management and Outcomes 4
Surgery
- Nausea and vomiting management 3

Co-authors: Keiichi Iwabuchi Reiko Woodhams Shinichi Kan Hirofumi Hata Keiji Matsunaga Kazushige Hayakawa Masahiko Watanabe Masanori Ozaki
Cited by: Radiology, Nuclear Medicine and Imaging Oncology Cancer Research
Journals: Journal of Clinical Oncology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Cancer (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Masaru Kuranami

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Masaru Kuranami

Since Specialization

Citations

This map shows the geographic impact of Masaru Kuranami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Kuranami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Kuranami more than expected).

Fields of papers citing papers by Masaru Kuranami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Kuranami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Kuranami. The network helps show where Masaru Kuranami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masaru Kuranami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masaru Kuranami Line = papers co-authored together Masaru Kuranami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study Cancer ·Toru Watanabe,Masaru Kuranami,Kenichi Inoue,Norikazu Masuda,Kenjiro Aogi,Shinji Ohno,Hiroji Iwata,Hirofumi Mukai,Yukari Uemura,Yasuo Ohashi	2017	28
2	Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up. PubMed ·Hiroshi Nishimiya,Yoshimasa Kosaka,Keishi Yamashita,Naoko Minatani,Mariko Kikuchi,Akira Ema,Kazunori Nakamura,Mina Waraya,Norihiko Sengoku,Hirokazu Tanino,Masaru Kuranami,Masahiko Watanabe,(unknown)	2014	13
3	The Relationship Between Emotional Suppression and Psychological Distress in Breast Cancer Patients After Surgery Japanese Journal of Clinical Oncology ·Yuki Nakatani,Yumi Iwamitsu,Masaru Kuranami,S Okazaki,Hiroe Shikanai,Kenji Yamamoto,Masahiko Watanabe,Hiroaki Miyaoka	2014	22
4	Predictors of psychological distress in breast cancer patients after surgery Yuki Nakatani,Yumi Iwamitsu,Masaru Kuranami	2013	9
5	[Efficacy and safety of lidocaine hydrochloride jelly for the treatment of pain caused by breast cancer metastases to the skin]. PubMed ·Mina Waraya,Yoshimasa Kosaka,Norihiko Sengoku,Mariko Kikuchi,Hiroshi Nishimiya,Takumo Enomoto,Masaru Kuranami,Masahiko Watanabe	2012	1
6	Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer Breast Cancer Research ·Yoshimasa Kosaka,Akemi Kataoka,Hiroshi Yamaguchi,Hiroaki Ueo,Sayuri Akiyoshi,Norihiko Sengoku,Masaru Kuranami,Shinji Ohno,Masahiko Watanabe,Koshi Mimori,Masaki Mori	2012	7
7	Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer Cancer Science ·Hideo Inaji,Hiroji Iwata,Takahiro Nakayama,Naohito Yamamoto,Yasuyuki Sato,Yutaka Tokuda,Kenjiro Aogi,Shigehira Saji,Kenichi Watanabe,Tsuyoshi Saito,Masayuki Yoshida,Nobuaki Sato,Toshiaki Saeki,Yuichi Takatsuka,Masaru Kuranami,Hiroko Yamashita,Atsushi Kikuchi,Toshio Tabei,Tadashi Ikeda,Shinzaburo Noguchi	2012	6
8	Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Supportive Care in Cancer ·Kojiro Shimozuma,Yasuo Ohashi,Ayano Takeuchi,Toshihiko Aranishi,Satoshi Morita,Katsumasa Kuroi,Shozo Ohsumi,Haruhiko Makino,Noriyuki Katsumata,Masaru Kuranami,Kimito Suemasu,Toru Watanabe,Frederick H. Hausheer	2012	79
9	Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls Breast Cancer ·Noriko Ando-Tanabe,Yumi Iwamitsu,Masaru Kuranami,S Okazaki,Hiroe Yasuda,Yuki Nakatani,Kenji Yamamoto,Masahiko Watanabe,Hitoshi Miyaoka	2012	37
10	Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery: The N-SAS BC 02 Trial Value in Health ·Takeru Shiroiwa,Takashi Fukuda,Kojiro Shimozuma,Masaru Kuranami,Kimito Suemasu,Yasuo Ohashi,Toru Watanabe	2011	10
11	Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints Familial Cancer ·Noriko Ando,Yumi Iwamitsu,Masaru Kuranami,S Okazaki,Kenji Yamamoto,Masahiko Watanabe,Hitoshi Miyaoka	2011	2
12	A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy Supportive Care in Cancer ·Kenjiro Aogi,Hiroshi Sakai,Hirohisa Yoshizawa,Norikazu Masuda,Nobuyuki Katakami,Yasuhiro Yanagita,Kenichi Inoue,Masaru Kuranami,Mitsuhiro Mizutani,Noriyuki Masuda	2011	24
13	Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imaging and Pathologic Findings Radiology ·Reiko Woodhams,Satoko Kakita,Hirofumi Hata,Keiichi Iwabuchi,Masaru Kuranami,Shiva Gautam,Hiroto Hatabu,Shinichi Kan,Carolyn E. Mountford	2010	113
14	The psychological responses of outpatient breast cancer patients before and during first medical consultation Palliative & Supportive Care ·S Okazaki,Yumi Iwamitsu,Masaru Kuranami,Keiko Todoroki,Shimako Suzuki,Kenji Yamamoto,Masashi Hagino,Masahiko Watanabe,Hitoshi Miyaoka	2009	8
15	Interaction Between Stromal Fibroblasts and Colorectal Cancer Cells in the Expression of Vascular Endothelial Growth Factor Journal of Surgical Research ·Yoshitomo Koshida,Masaru Kuranami,Masahiko Watanabe	2006	20
16	ADC Mapping of Benign and Malignant Breast Tumors Magnetic Resonance in Medical Sciences ·Reiko Woodhams,Keiji Matsunaga,Shinichi Kan,Hirofumi Hata,Masanori Ozaki,Keiichi Iwabuchi,Masaru Kuranami,Masahiko Watanabe,Kazushige Hayakawa	2005	278
17	Specific Enhanced Expression of Platelet-Derived Endothelial Cell Growth Factor in Submucosa of Human Colorectal Cancer Diseases of the Colon & Rectum ·Tadashi Nozawa,Takumo Enomoto,Yoshitomo Koshida,Yuichi Sato,Masaru Kuranami	2004	12
18	Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer Cancer Chemotherapy and Pharmacology ·Bruno Reigner,Toru Watanabe,Johannes Sch�ller,Helen Lucraft,Yasutsuna Sasaki,John Bridgewater,Toshiaki Saeki,James J McAleer,Masaru Kuranami,Christopher Poole,Mitsunori Kimura,Jayne Monkhouse,Cahit Yorulmaz,E. Weidekamm,Susan Grange	2003	41
19	Analyses of protein kinase c isoform expression in a colorectal cancer liver metastasis model The American Journal of Surgery ·Masaru Kuranami,Alfred M. Cohen,José G. Guillem	1995	8
20	In vitro Sensitivity Test of Breast Cancer Cells to Hormonal Agents in a Radionucleotide‐incorporation Assay Japanese Journal of Cancer Research ·Toru Watanabe,Wu Junzheng,Kiyoshi Morikawa,Masahiro Fuchigami,Masaru Kuranami,Isamu Adachi,Ken Yamaguchi,Kaoru Abe	1990	11

About Masaru Kuranami

Masaru Kuranami is a scholar working on Oncology, Dermatology and Cancer Research, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (8 papers), Family Support in Illness (6 papers), Chemotherapy-related skin toxicity (6 papers), Cancer survivorship and care (6 papers), Cancer Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Nausea and vomiting management (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (646 citations), Oncology (409 citations) and Cancer Research (146 citations). Masaru Kuranami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Keiichi Iwabuchi, Reiko Woodhams, Shinichi Kan, Hirofumi Hata, Keiji Matsunaga, Kazushige Hayakawa, Masahiko Watanabe, Masahiko Watanabe, Masanori Ozaki and Yumi Iwamitsu. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact